Advanced Transplant Diagnostics And Immunogenetics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 230.11%
(FY 2022)
- Profit 4099.43%
(FY 2022)
- Ebitda 2534.74%
(FY 2022)
- Net Worth 876.68%
(FY 2022)
- Total Assets 31.35%
(FY 2022)
About Advanced Transplant Diagnostics And Immunogenetics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Shah, Shruti Tapiawala, Hepal Vora, and Two other members serve as directors at the Company.
- CIN/LLPIN
U93090MH2019PTC330328
- Company No.
330328
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2019
- Date of AGM
26 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Advanced Transplant Diagnostics And Immunogenetics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shruti Tapiawala  | Director | 09-Sep-2019 | Current |
| Bharat Shah | Director | 09-Sep-2019 | Current |
| Hepal Vora | Director | 06-Nov-2020 | Current |
| Zaheer Virani | Director | 06-Nov-2020 | Current |
| Prashant Rajput | Director | 06-Nov-2020 | Current |
Financial Performance of Advanced Transplant Diagnostics And Immunogenetics.
Advanced Transplant Diagnostics And Immunogenetics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 230.11% increase. The company also saw a substantial improvement in profitability, with a 4099.43% increase in profit. The company's net worth Soared by an impressive increase of 876.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Transplant Diagnostics And Immunogenetics?
Unlock access to Advanced Transplant Diagnostics And Immunogenetics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Centre For Digestive And Kidney Diseases (India) Private LimitedActive 20 years 7 monthsBharat Shah is a mutual person
Atdi Lab Private LimitedActive 4 years 17 daysBharat Shah, Shruti Tapiawala and 3 more are mutual person
- Advanced Renal Replacement Therapies Center Private LimitedActive 1 year 8 months
Bharat Shah, Shruti Tapiawala and 2 more are mutual person
- Atdi Aurangabad Lab Private LimitedActive 6 months 30 days
Shruti Tapiawala, Hepal Vora and 2 more are mutual person
- Maxxfresh Agro Farmer Producer Company LimitedActive 4 years 6 months
Prashant Rajput is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanced Transplant Diagnostics And Immunogenetics?
Unlock and access historical data on people associated with Advanced Transplant Diagnostics And Immunogenetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Transplant Diagnostics And Immunogenetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Transplant Diagnostics And Immunogenetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
